And the entry firm should make low-price strategy to survive in the market.
同时,进入厂商需要采取低价策略在市场立足。
The product price of the incumbent firm is higher than the price of entry firm and the incumbent will gain higher profits.
在位厂商的产品定价高于进入厂商的产品定价,在位厂商获取更高的利润。
Michael Kamarck of Merck, an American drugs firm which moved into biosimilars in 2008, thinks the barriers to entry are so great that “only a handful” of firms will be able to pull it off.
一家于2008年转向生物仿制制药的美国制药公司---默克公司认为进入生物仿制制药这个领域的障碍是如此之大以至于“只有几家”公司有能力成功进入。
应用推荐